Skip to content

Whole exome sequencing analysis to identify molecular targets in malignant lymphoma

Whole exome sequencing analysis to identify molecular targets in malignant lymphoma - Whole exome sequencing of malignant lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013723
Enrollment
10
Registered
2014-04-15
Start date
2013-09-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Lymphoma

Interventions

None listed

Sponsors

National Cancer Center Hospital East
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
Identification of New Candidate Therapeutic Target Genes

Countries

Japan

Contacts

Public ContactMasahiko Nezu

National Cancer Center Hospital East Department of Hematology

mnezu@east.ncc.go.jp+81-4-7133-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026